Barbara Davis
Concepts (460)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of publications
|
Most recent publication
|
Publications by all authors
|
Why?
|
|---|
Leiomyoma | 11 | 2000 | 34 |
Why?
| Uterine Neoplasms | 11 | 1995 | 52 |
Why?
| Ovary | 11 | 1995 | 50 |
Why?
| Diethylhexyl Phthalate | 6 | 1994 | 2 |
Why?
| Ovarian Neoplasms | 5 | 1996 | 64 |
Why?
| Reproduction | 8 | 1995 | 21 |
Why?
| Estradiol | 11 | 1994 | 78 |
Why?
| BRCA2 Protein | 8 | 1998 | 9 |
Why?
| Granulosa Cells | 6 | 1994 | 9 |
Why?
| Prostaglandin-Endoperoxide Synthases | 5 | 1996 | 66 |
Why?
| Germ-Line Mutation | 2 | 2005 | 22 |
Why?
| Genes, p53 | 3 | 2003 | 43 |
Why?
| Myometrium | 5 | 2000 | 13 |
Why?
| Animals | 56 | 1981 | 1031 |
Why?
| Female | 55 | 1994 | 1643 |
Why?
| Phthalic Acids | 4 | 2002 | 7 |
Why?
| Diethylstilbestrol | 7 | 2000 | 13 |
Why?
| Isoenzymes | 5 | 1996 | 144 |
Why?
| Pregnancy | 16 | 1995 | 455 |
Why?
| Meiosis | 2 | 1998 | 15 |
Why?
| Rats | 25 | 1981 | 530 |
Why?
| Endocrine Glands | 2 | 2001 | 6 |
Why?
| Transcription Factors | 7 | 1998 | 201 |
Why?
| Mammary Glands, Animal | 4 | 1998 | 14 |
Why?
| Women's Health | 2 | 2003 | 40 |
Why?
| Radiation, Ionizing | 2 | 2005 | 21 |
Why?
| Carcinogens | 5 | 2000 | 40 |
Why?
| Genes, BRCA2 | 2 | 2002 | 9 |
Why?
| Neoplasms | 4 | 2001 | 239 |
Why?
| Acetic Acids | 2 | 1997 | 31 |
Why?
| Decision Making | 1 | 2009 | 130 |
Why?
| Aromatase | 3 | 1994 | 3 |
Why?
| Neoplasm Proteins | 5 | 1998 | 110 |
Why?
| RNA, Messenger | 4 | 2001 | 394 |
Why?
| Gene Expression Regulation, Neoplastic | 4 | 2000 | 126 |
Why?
| Fanconi Anemia Complementation Group D2 Protein | 1 | 2005 | 1 |
Why?
| Mice | 22 | 1985 | 623 |
Why?
| Estrus | 7 | 1994 | 10 |
Why?
| Uterus | 5 | 1995 | 49 |
Why?
| Progesterone | 7 | 1994 | 42 |
Why?
| Neoplasms, Radiation-Induced | 1 | 2006 | 31 |
Why?
| Gene Expression Regulation, Developmental | 5 | 1998 | 119 |
Why?
| Recombination, Genetic | 1 | 2005 | 78 |
Why?
| Receptors, Cytoplasmic and Nuclear | 2 | 2000 | 49 |
Why?
| DNA Repair | 1 | 2005 | 47 |
Why?
| Mammary Neoplasms, Experimental | 3 | 2001 | 37 |
Why?
| Follicle Stimulating Hormone | 4 | 1994 | 36 |
Why?
| Perindopril | 1 | 2003 | 3 |
Why?
| Diabetic Nephropathies | 1 | 2003 | 18 |
Why?
| Peptidyl-Dipeptidase A | 1 | 2003 | 5 |
Why?
| Tumor Suppressor Protein p53 | 2 | 2001 | 82 |
Why?
| Enoyl-CoA Hydratase | 1 | 2003 | 2 |
Why?
| Carcinogens, Environmental | 2 | 1996 | 6 |
Why?
| Receptors, Oxytocin | 1 | 2003 | 1 |
Why?
| Ovulation | 3 | 1994 | 11 |
Why?
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2003 | 34 |
Why?
| Connexin 43 | 1 | 2003 | 14 |
Why?
| Genes, BRCA1 | 3 | 1998 | 12 |
Why?
| Multienzyme Complexes | 1 | 2003 | 45 |
Why?
| Disease Models, Animal | 7 | 1995 | 349 |
Why?
| Carcinogenicity Tests | 1 | 2002 | 5 |
Why?
| Kidney | 2 | 2001 | 223 |
Why?
| Mammary Neoplasms, Animal | 1 | 2002 | 13 |
Why?
| Blotting, Western | 5 | 2001 | 275 |
Why?
| Dinoprostone | 2 | 1999 | 55 |
Why?
| Cyclic AMP | 3 | 1994 | 89 |
Why?
| Genitalia | 1 | 2001 | 9 |
Why?
| Rodentia | 1 | 2001 | 11 |
Why?
| Neoplasms, Hormone-Dependent | 1 | 2000 | 12 |
Why?
| Labor, Obstetric | 1 | 2000 | 22 |
Why?
| Muscle, Smooth | 2 | 2000 | 69 |
Why?
| Chimera | 2 | 1999 | 22 |
Why?
| Mice, Knockout | 7 | 1996 | 265 |
Why?
| Ethylene Glycols | 2 | 1997 | 10 |
Why?
| Corpus Luteum | 2 | 1997 | 7 |
Why?
| Solvents | 2 | 1997 | 28 |
Why?
| Infertility, Female | 1 | 2001 | 17 |
Why?
| Antigens, CD | 1 | 2002 | 128 |
Why?
| Prostaglandins | 1 | 2000 | 41 |
Why?
| Islets of Langerhans | 3 | 1983 | 26 |
Why?
| Rodent Diseases | 1 | 1999 | 6 |
Why?
| Teratocarcinoma | 1 | 1999 | 8 |
Why?
| Mercury | 1 | 2001 | 25 |
Why?
| Proto-Oncogene Proteins | 1 | 2002 | 113 |
Why?
| Genital Neoplasms, Male | 1 | 1999 | 16 |
Why?
| Anovulation | 1 | 1999 | 2 |
Why?
| Receptors, Estrogen | 2 | 1997 | 44 |
Why?
| Cyclooxygenase 1 | 5 | 1996 | 41 |
Why?
| Cells, Cultured | 6 | 1994 | 447 |
Why?
| Mutation | 1 | 2005 | 340 |
Why?
| Membrane Proteins | 6 | 1996 | 233 |
Why?
| Membrane Glycoproteins | 1 | 2002 | 154 |
Why?
| Tetrachlorodibenzodioxin | 1 | 2000 | 18 |
Why?
| BRCA1 Protein | 2 | 1997 | 3 |
Why?
| Ovarian Follicle | 2 | 1994 | 13 |
Why?
| Supraoptic Nucleus | 3 | 1985 | 8 |
Why?
| Estrogens, Non-Steroidal | 2 | 2007 | 7 |
Why?
| Interleukin-1 | 1 | 1999 | 109 |
Why?
| Cell Differentiation | 4 | 1999 | 262 |
Why?
| Lactation | 2 | 1997 | 22 |
Why?
| Mitosis | 1 | 1998 | 68 |
Why?
| Rats, Sprague-Dawley | 6 | 1994 | 257 |
Why?
| Pregnancy, Animal | 1 | 1997 | 20 |
Why?
| Cyclooxygenase 2 | 4 | 1996 | 77 |
Why?
| Genetic Predisposition to Disease | 5 | 2000 | 131 |
Why?
| Mice, Inbred C57BL | 6 | 1996 | 318 |
Why?
| Catecholamines | 2 | 1985 | 40 |
Why?
| Humans | 23 | 1981 | 1856 |
Why?
| Immunohistochemistry | 4 | 2002 | 355 |
Why?
| Prenatal Exposure Delayed Effects | 3 | 2001 | 46 |
Why?
| Rats, Inbred F344 | 4 | 1992 | 80 |
Why?
| Radioimmunoassay | 4 | 1994 | 81 |
Why?
| Male | 25 | 1984 | 1553 |
Why?
| Tumor Suppressor Proteins | 2 | 2005 | 51 |
Why?
| Immunosuppressive Agents | 1 | 1997 | 102 |
Why?
| Immune System | 3 | 1997 | 43 |
Why?
| Substantia Nigra | 2 | 1984 | 30 |
Why?
| Blood Pressure | 3 | 1986 | 205 |
Why?
| Dose-Response Relationship, Drug | 6 | 1994 | 431 |
Why?
| Mice, Inbred BALB C | 3 | 2000 | 176 |
Why?
| Aromatase Inhibitors | 2 | 2001 | 2 |
Why?
| Peroxisome Proliferators | 2 | 2001 | 4 |
Why?
| Time Factors | 5 | 1994 | 896 |
Why?
| Neoplasm Metastasis | 2 | 2002 | 112 |
Why?
| Insulin | 4 | 1985 | 129 |
Why?
| Adult | 10 | 2002 | 1317 |
Why?
| Fertility | 3 | 1995 | 32 |
Why?
| Premenopause | 2 | 2002 | 16 |
Why?
| Body Weight | 6 | 1984 | 178 |
Why?
| Young Adult | 3 | 2008 | 380 |
Why?
| Mice, Transgenic | 3 | 2000 | 209 |
Why?
| Environmental Exposure | 2 | 2002 | 75 |
Why?
| Peer Review, Health Care | 1 | 2010 | 6 |
Why?
| Exons | 3 | 2002 | 91 |
Why?
| Cell Aging | 1 | 2010 | 31 |
Why?
| Vasopressins | 2 | 1986 | 21 |
Why?
| Staff Development | 1 | 2010 | 23 |
Why?
| Sodium-Potassium-Exchanging ATPase | 1 | 2009 | 22 |
Why?
| Trophoblasts | 1 | 2010 | 13 |
Why?
| Polymerase Chain Reaction | 4 | 1999 | 279 |
Why?
| Steroids | 1 | 2010 | 38 |
Why?
| Enzyme Inhibitors | 2 | 2001 | 216 |
Why?
| Receptors, Aryl Hydrocarbon | 2 | 2000 | 23 |
Why?
| Hysterectomy | 1 | 2009 | 23 |
Why?
| Testis | 3 | 1998 | 54 |
Why?
| Morphine | 1 | 2009 | 38 |
Why?
| Uterine Hemorrhage | 1 | 2009 | 17 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2001 | 243 |
Why?
| Pelvic Pain | 1 | 2009 | 17 |
Why?
| Tumor Cells, Cultured | 2 | 2000 | 233 |
Why?
| Placenta | 1 | 2010 | 48 |
Why?
| 8-Bromo Cyclic Adenosine Monophosphate | 2 | 1994 | 16 |
Why?
| Students, Medical | 1 | 2010 | 66 |
Why?
| Embolization, Therapeutic | 1 | 2009 | 37 |
Why?
| Middle Aged | 6 | 2002 | 1161 |
Why?
| Chorionic Gonadotropin | 2 | 1997 | 27 |
Why?
| Luteinizing Hormone | 3 | 1994 | 33 |
Why?
| Genotype | 3 | 1997 | 175 |
Why?
| Diet | 2 | 1992 | 87 |
Why?
| Mice, Mutant Strains | 2 | 1997 | 77 |
Why?
| Immunoblotting | 2 | 2004 | 119 |
Why?
| Water-Electrolyte Balance | 1 | 1987 | 28 |
Why?
| Renin | 1 | 1987 | 26 |
Why?
| Magnetic Resonance Imaging | 2 | 2008 | 294 |
Why?
| Autonomic Nervous System | 2 | 1983 | 41 |
Why?
| Cell Division | 3 | 1997 | 273 |
Why?
| In Situ Hybridization | 2 | 1997 | 135 |
Why?
| Signal Transduction | 4 | 1999 | 313 |
Why?
| Health Knowledge, Attitudes, Practice | 1 | 2009 | 145 |
Why?
| Plasticizers | 1 | 2005 | 2 |
Why?
| PPAR alpha | 1 | 2005 | 4 |
Why?
| Comet Assay | 1 | 2005 | 6 |
Why?
| Mitomycin | 1 | 2005 | 13 |
Why?
| Rad51 Recombinase | 1 | 2005 | 4 |
Why?
| Diabetes Insipidus | 1 | 1985 | 5 |
Why?
| Genes | 2 | 1997 | 82 |
Why?
| Arginine Vasopressin | 1 | 1985 | 21 |
Why?
| Animals, Newborn | 4 | 1995 | 175 |
Why?
| Organ Size | 3 | 1997 | 118 |
Why?
| Fluorescent Antibody Technique, Indirect | 1 | 2005 | 36 |
Why?
| Stomach Neoplasms | 1 | 2006 | 28 |
Why?
| Penetrance | 1 | 2005 | 3 |
Why?
| Osteosarcoma | 1 | 2006 | 31 |
Why?
| Flow Cytometry | 2 | 2001 | 216 |
Why?
| Reinforcement (Psychology) | 1 | 2005 | 14 |
Why?
| Analysis of Variance | 3 | 1994 | 339 |
Why?
| Disease Progression | 2 | 2002 | 244 |
Why?
| Glucagon | 1 | 1985 | 31 |
Why?
| Phenotype | 2 | 2000 | 303 |
Why?
| Cell Line, Tumor | 2 | 2004 | 208 |
Why?
| Reference Values | 2 | 2003 | 278 |
Why?
| Cell Proliferation | 2 | 2005 | 227 |
Why?
| Nicotine | 1 | 2005 | 19 |
Why?
| Embryo, Mammalian | 1 | 2005 | 99 |
Why?
| Rats, Inbred SHR | 2 | 1986 | 24 |
Why?
| Cocaine | 1 | 2005 | 33 |
Why?
| PPAR gamma | 1 | 2005 | 38 |
Why?
| Bone Neoplasms | 1 | 2006 | 83 |
Why?
| Rats, Inbred Strains | 5 | 1984 | 170 |
Why?
| Genes, fos | 1 | 2003 | 14 |
Why?
| European Continental Ancestry Group | 3 | 2008 | 117 |
Why?
| Climacteric | 1 | 2003 | 3 |
Why?
| Histones | 1 | 2005 | 42 |
Why?
| Oceanic Ancestry Group | 1 | 2003 | 3 |
Why?
| Art | 1 | 2003 | 6 |
Why?
| DNA Methylation | 1 | 2003 | 29 |
Why?
| Epithelium | 1 | 2004 | 101 |
Why?
| Carcinoma, Squamous Cell | 1 | 2006 | 111 |
Why?
| Insulin-Like Growth Factor I | 1 | 2004 | 64 |
Why?
| Hypertension | 2 | 1986 | 161 |
Why?
| Embryonic and Fetal Development | 3 | 1995 | 52 |
Why?
| 17-Hydroxysteroid Dehydrogenases | 1 | 2003 | 4 |
Why?
| Survival Rate | 1 | 2006 | 250 |
Why?
| Blood Glucose | 3 | 1992 | 99 |
Why?
| Aryl Hydrocarbon Hydroxylases | 1 | 2003 | 22 |
Why?
| Retinoid X Receptors | 1 | 2003 | 18 |
Why?
| Esters | 1 | 2003 | 20 |
Why?
| Receptors, Retinoic Acid | 1 | 2003 | 19 |
Why?
| Repressor Proteins | 1 | 2005 | 96 |
Why?
| Pregnancy Complications, Neoplastic | 1 | 2003 | 24 |
Why?
| Diabetes Mellitus, Experimental | 1 | 2003 | 36 |
Why?
| Oxytocin | 1 | 2003 | 15 |
Why?
| Gestational Age | 2 | 2000 | 114 |
Why?
| Parity | 1 | 2003 | 28 |
Why?
| Antigens, CD82 | 1 | 2002 | 1 |
Why?
| Antigens, CD9 | 1 | 2002 | 4 |
Why?
| Maternal Exposure | 2 | 1995 | 24 |
Why?
| Health Education | 1 | 2003 | 57 |
Why?
| Cadherins | 1 | 2002 | 32 |
Why?
| Neoplasm Staging | 1 | 2004 | 125 |
Why?
| Gene Expression | 2 | 2003 | 291 |
Why?
| Polycystic Ovary Syndrome | 1 | 2002 | 12 |
Why?
| Kinetics | 1 | 2005 | 349 |
Why?
| Cell Nucleus | 1 | 2005 | 169 |
Why?
| Fibroblasts | 1 | 2005 | 179 |
Why?
| Insecticides | 2 | 1997 | 11 |
Why?
| Ethnic Groups | 1 | 2003 | 95 |
Why?
| Toxicity Tests | 1 | 2002 | 17 |
Why?
| Heptachlor | 1 | 2001 | 1 |
Why?
| Gonadotropins, Equine | 1 | 2001 | 2 |
Why?
| Breast Neoplasms | 2 | 2003 | 185 |
Why?
| Cholesterol Side-Chain Cleavage Enzyme | 1 | 2001 | 5 |
Why?
| Fungicides, Industrial | 1 | 2001 | 7 |
Why?
| Sexual Maturation | 1 | 2001 | 11 |
Why?
| Volatilization | 1 | 2001 | 9 |
Why?
| Genes, APC | 1 | 2001 | 6 |
Why?
| Metaplasia | 1 | 2001 | 18 |
Why?
| Ovarian Diseases | 1 | 2001 | 8 |
Why?
| Nervous System | 1 | 2001 | 52 |
Why?
| Triazoles | 1 | 2001 | 31 |
Why?
| Up-Regulation | 1 | 2003 | 183 |
Why?
| Sertoli Cell Tumor | 1 | 2000 | 1 |
Why?
| Diethylnitrosamine | 1 | 2000 | 5 |
Why?
| Health Promotion | 1 | 2003 | 76 |
Why?
| Down-Regulation | 1 | 2002 | 150 |
Why?
| Treatment Outcome | 1 | 2009 | 661 |
Why?
| Neoplasms, Experimental | 1 | 2002 | 72 |
Why?
| Vagina | 2 | 1997 | 30 |
Why?
| Longevity | 1 | 2001 | 20 |
Why?
| Risk Assessment | 2 | 2002 | 324 |
Why?
| Administration, Inhalation | 1 | 2001 | 60 |
Why?
| Pyrimidines | 1 | 2001 | 49 |
Why?
| Fetal Death | 1 | 2000 | 30 |
Why?
| Drug Synergism | 1 | 2000 | 104 |
Why?
| Gene Deletion | 2 | 1996 | 121 |
Why?
| Disorders of Sex Development | 1 | 1999 | 7 |
Why?
| Incidence | 2 | 1996 | 336 |
Why?
| Hydranencephaly | 1 | 1999 | 1 |
Why?
| Parvovirus | 1 | 1999 | 1 |
Why?
| Cat Diseases | 1 | 1999 | 5 |
Why?
| Proteins | 1 | 2003 | 192 |
Why?
| Parvoviridae Infections | 1 | 1999 | 12 |
Why?
| Molecular Chaperones | 1 | 1999 | 30 |
Why?
| Drug Administration Schedule | 1 | 2000 | 191 |
Why?
| HSP70 Heat-Shock Proteins | 1 | 1999 | 27 |
Why?
| African Continental Ancestry Group | 2 | 2010 | 80 |
Why?
| Environmental Pollutants | 1 | 2000 | 35 |
Why?
| Cerebellum | 1 | 1999 | 59 |
Why?
| Apoptosis | 1 | 2005 | 265 |
Why?
| Methoxychlor | 1 | 1997 | 1 |
Why?
| Gene Expression Profiling | 1 | 2000 | 138 |
Why?
| DNA-Binding Proteins | 1 | 2003 | 204 |
Why?
| Morphogenesis | 1 | 1998 | 47 |
Why?
| Theca Cells | 1 | 1997 | 2 |
Why?
| Hypophysectomy | 1 | 1997 | 11 |
Why?
| Brain | 3 | 1992 | 305 |
Why?
| Histocytochemistry | 3 | 1981 | 65 |
Why?
| Adenocarcinoma | 1 | 2001 | 167 |
Why?
| Nervous System Diseases | 1 | 1997 | 78 |
Why?
| Rats, Mutant Strains | 2 | 2005 | 14 |
Why?
| Administration, Oral | 1 | 1997 | 170 |
Why?
| Environment | 1 | 1996 | 43 |
Why?
| Indium | 1 | 1995 | 3 |
Why?
| Abnormalities, Drug-Induced | 1 | 1995 | 16 |
Why?
| Hydrogen-Ion Concentration | 1 | 1997 | 176 |
Why?
| Teratogens | 1 | 1995 | 17 |
Why?
| Cell Cycle | 1 | 1997 | 121 |
Why?
| Ethyl Chloride | 1 | 1995 | 1 |
Why?
| Hydrocarbons, Brominated | 1 | 1995 | 2 |
Why?
| Dactinomycin | 1 | 1994 | 40 |
Why?
| Mutagens | 1 | 1995 | 29 |
Why?
| Cycloheximide | 1 | 1994 | 51 |
Why?
| Brain Mapping | 2 | 1984 | 61 |
Why?
| Fetus | 1 | 1995 | 105 |
Why?
| Cell Count | 1 | 1994 | 163 |
Why?
| Testosterone | 1 | 1994 | 57 |
Why?
| Australia | 2 | 2002 | 27 |
Why?
| Image Processing, Computer-Assisted | 1 | 1994 | 138 |
Why?
| Cell Survival | 1 | 1994 | 229 |
Why?
| Discrimination Learning | 1 | 1992 | 20 |
Why?
| Hemoglobin A, Glycosylated | 1 | 1992 | 22 |
Why?
| Orientation | 1 | 1992 | 29 |
Why?
| Estrogens, Conjugated (USP) | 1 | 2010 | 5 |
Why?
| Medroxyprogesterone Acetate | 1 | 2010 | 5 |
Why?
| Cross-Sectional Studies | 2 | 2002 | 253 |
Why?
| Immunoenzyme Techniques | 3 | 1981 | 125 |
Why?
| Heterozygote | 2 | 2000 | 80 |
Why?
| Myenteric Plexus | 1 | 2009 | 4 |
Why?
| Enkephalin, Ala(2)-MePhe(4)-Gly(5)- | 1 | 2009 | 7 |
Why?
| Drug Tolerance | 1 | 2009 | 26 |
Why?
| Weight Gain | 1 | 2009 | 30 |
Why?
| Problem-Based Learning | 1 | 2010 | 36 |
Why?
| Guinea Pigs | 1 | 2009 | 76 |
Why?
| Adenine | 1 | 2009 | 26 |
Why?
| Schools, Medical | 1 | 2010 | 46 |
Why?
| Protein Isoforms | 1 | 2009 | 86 |
Why?
| Sensitivity and Specificity | 2 | 2002 | 427 |
Why?
| Aging | 2 | 1992 | 275 |
Why?
| Educational Status | 1 | 2010 | 99 |
Why?
| Educational Measurement | 1 | 2010 | 60 |
Why?
| Program Evaluation | 1 | 2010 | 115 |
Why?
| Killer Cells, Natural | 2 | 1997 | 62 |
Why?
| Learning | 1 | 2010 | 66 |
Why?
| Gene Targeting | 2 | 1997 | 51 |
Why?
| Education, Medical | 1 | 2010 | 79 |
Why?
| Spleen | 2 | 1997 | 129 |
Why?
| Prevalence | 1 | 2010 | 281 |
Why?
| Questionnaires | 2 | 2002 | 360 |
Why?
| Microscopy, Fluorescence | 2 | 1985 | 137 |
Why?
| Drinking | 1 | 1987 | 14 |
Why?
| Diuresis | 1 | 1987 | 20 |
Why?
| Menstrual Cycle | 1 | 2007 | 13 |
Why?
| Longitudinal Studies | 1 | 2008 | 195 |
Why?
| Calcium-Binding Protein, Vitamin D-Dependent | 1 | 2007 | 14 |
Why?
| Base Sequence | 2 | 2000 | 371 |
Why?
| Receptors, Progesterone | 1 | 2007 | 28 |
Why?
| Estrogens | 1 | 2007 | 45 |
Why?
| African Americans | 1 | 2008 | 108 |
Why?
| Oligonucleotide Array Sequence Analysis | 1 | 2008 | 135 |
Why?
| Phenylurea Compounds | 1 | 2005 | 1 |
Why?
| PPAR-beta | 1 | 2005 | 1 |
Why?
| Butyric Acids | 1 | 2005 | 8 |
Why?
| Immunologic Techniques | 1 | 1985 | 19 |
Why?
| Hydroxydopamines | 1 | 1985 | 13 |
Why?
| Oxidopamine | 1 | 1985 | 21 |
Why?
| Transcription, Genetic | 1 | 2010 | 253 |
Why?
| Gonadal Steroid Hormones | 1 | 2005 | 30 |
Why?
| Norepinephrine | 1 | 1986 | 68 |
Why?
| Thiazolidinediones | 1 | 2005 | 35 |
Why?
| Thiazoles | 1 | 2005 | 50 |
Why?
| Statistics, Nonparametric | 1 | 2005 | 141 |
Why?
| Infant, Newborn | 1 | 2010 | 389 |
Why?
| Conditioning, Operant | 1 | 2005 | 17 |
Why?
| Inflammation | 2 | 1997 | 208 |
Why?
| Pancreatic Hormones | 1 | 1983 | 4 |
Why?
| Pamphlets | 1 | 2003 | 5 |
Why?
| Kidney Diseases | 1 | 1985 | 90 |
Why?
| Motor Activity | 1 | 2005 | 104 |
Why?
| Mutagenicity Tests | 1 | 2003 | 11 |
Why?
| Cocarcinogenesis | 1 | 2003 | 6 |
Why?
| Hypothalamus | 1 | 1983 | 33 |
Why?
| Genes, ras | 1 | 2003 | 24 |
Why?
| Maternal Age | 1 | 2003 | 27 |
Why?
| Body Constitution | 1 | 2002 | 10 |
Why?
| Proto-Oncogene Proteins c-fos | 1 | 2003 | 35 |
Why?
| Hirsutism | 1 | 2002 | 6 |
Why?
| Culture | 1 | 2003 | 41 |
Why?
| Drug Evaluation, Preclinical | 1 | 2003 | 65 |
Why?
| Biological Assay | 1 | 2003 | 58 |
Why?
| Cats | 2 | 1981 | 71 |
Why?
| Dopamine | 1 | 1984 | 62 |
Why?
| Inbreeding | 1 | 2002 | 5 |
Why?
| Urinalysis | 1 | 2002 | 17 |
Why?
| Half-Life | 1 | 2002 | 69 |
Why?
| Transfection | 1 | 2005 | 237 |
Why?
| Specimen Handling | 1 | 2002 | 52 |
Why?
| Risk | 1 | 2003 | 203 |
Why?
| Insulin Resistance | 1 | 2002 | 37 |
Why?
| Gastrointestinal Hormones | 1 | 1981 | 5 |
Why?
| Motilin | 1 | 1981 | 2 |
Why?
| Intestine, Large | 1 | 1981 | 7 |
Why?
| Chromatography, High Pressure Liquid | 1 | 2002 | 121 |
Why?
| Health Surveys | 1 | 2002 | 103 |
Why?
| Duodenum | 1 | 1981 | 24 |
Why?
| Heptachlor Epoxide | 1 | 2001 | 1 |
Why?
| Pilot Projects | 1 | 2003 | 264 |
Why?
| Body Mass Index | 1 | 2002 | 122 |
Why?
| Litter Size | 1 | 2001 | 4 |
Why?
| Ethylnitrosourea | 1 | 2001 | 10 |
Why?
| Hypersensitivity, Delayed | 1 | 2001 | 35 |
Why?
| Androgens | 1 | 2002 | 38 |
Why?
| Immunoglobulin M | 1 | 2001 | 81 |
Why?
| Pedigree | 1 | 2001 | 84 |
Why?
| Genes, Lethal | 1 | 2000 | 13 |
Why?
| Tissue Distribution | 1 | 2001 | 124 |
Why?
| Fallopian Tubes | 1 | 2000 | 7 |
Why?
| Intestine, Small | 1 | 1981 | 55 |
Why?
| Crosses, Genetic | 1 | 2000 | 47 |
Why?
| Hypertrophy | 1 | 2000 | 46 |
Why?
| United States | 1 | 2008 | 604 |
Why?
| Fibrosis | 1 | 2000 | 46 |
Why?
| Antibody Formation | 1 | 2001 | 89 |
Why?
| Testicular Hormones | 1 | 1999 | 3 |
Why?
| Anti-Mullerian Hormone | 1 | 1999 | 3 |
Why?
| T-Lymphocyte Subsets | 1 | 2001 | 70 |
Why?
| Clusterin | 1 | 1999 | 6 |
Why?
| SOX9 Transcription Factor | 1 | 1999 | 5 |
Why?
| Seminiferous Tubules | 1 | 1999 | 7 |
Why?
| Endometriosis | 1 | 2000 | 14 |
Why?
| High Mobility Group Proteins | 1 | 1999 | 12 |
Why?
| Genetic Markers | 1 | 2000 | 78 |
Why?
| Estrogen Receptor beta | 1 | 1999 | 10 |
Why?
| Protein Structure, Tertiary | 1 | 2002 | 163 |
Why?
| Sertoli Cells | 1 | 1999 | 10 |
Why?
| Mice, Inbred C3H | 1 | 2000 | 86 |
Why?
| Estrogen Receptor alpha | 1 | 1999 | 20 |
Why?
| Growth Inhibitors | 1 | 1999 | 33 |
Why?
| Cytopathogenic Effect, Viral | 1 | 1999 | 19 |
Why?
| Vaccines, Attenuated | 1 | 1999 | 22 |
Why?
| Enzyme-Linked Immunosorbent Assay | 1 | 2001 | 224 |
Why?
| Biological Markers | 1 | 2002 | 262 |
Why?
| Reproducibility of Results | 1 | 2002 | 391 |
Why?
| Viral Vaccines | 1 | 1999 | 35 |
Why?
| Immunoglobulin G | 1 | 2001 | 191 |
Why?
| Glycoproteins | 1 | 1999 | 113 |
Why?
| Transcriptional Activation | 1 | 2000 | 99 |
Why?
| Hemolytic Plaque Technique | 1 | 1997 | 6 |
Why?
| Epithelial Cells | 1 | 2000 | 135 |
Why?
| Stomach Ulcer | 1 | 1997 | 8 |
Why?
| Cyclooxygenase Inhibitors | 1 | 1997 | 47 |
Why?
| Lymphocytes | 1 | 1997 | 142 |
Why?
| Behavior, Animal | 1 | 1997 | 77 |
Why?
| Cell Transformation, Neoplastic | 1 | 1997 | 86 |
Why?
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 1997 | 78 |
Why?
| Mice, Inbred ICR | 1 | 1995 | 34 |
Why?
| Culture Techniques | 1 | 1995 | 61 |
Why?
| Molecular Sequence Data | 1 | 2000 | 404 |
Why?
| Receptors, Cholinergic | 1 | 1992 | 15 |
Why?
| Saimiri | 1 | 1992 | 22 |
Why?
| Mental Recall | 1 | 1992 | 36 |
Why?
| Synaptic Transmission | 1 | 1992 | 58 |
Why?
| Energy Metabolism | 1 | 1992 | 80 |
Why?
| Macaca mulatta | 1 | 1992 | 71 |
Why?
| Aged | 1 | 2003 | 988 |
Why?
| Liver | 1 | 1995 | 248 |
Why?
| Rats, Inbred WKY | 1 | 1986 | 15 |
Why?
| Species Specificity | 1 | 1986 | 186 |
Why?
| Age Factors | 1 | 1986 | 480 |
Why?
| Intestinal Mucosa | 1 | 1981 | 56 |
Why?
| Dogs | 1 | 1981 | 159 |
Why?
|
|
Davis's Networks
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|
